
Analyses released yesterday and today show that the Australian government will achieve more than A$16 billion ($12.4 billion) in Pharmaceutical Benefits Scheme (PBS) savings from 2010-18, whilst listings of new medicines over this period will cost only A$6 billion.
The analysis conducted by PharmaDispatch, translates to government savings of more than A$2.70 for every A$1 spent on new medicines between 2010 and 2018.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze